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ABSTRACT 
Glycosylation is a group of post-translational modifications that displays a large variety of 
structures and are implicated in a plethora of biological processes. Therefore, studying 
glycosylation requires different technical approaches and reliable tools, lectins being part of 
them. Here we describe the use of the recombinant mushroom lectin PVL to discriminate O-
GlcNAcylation, a modification consisting in the attachment of a single N-acetylglucosamine 
residue to proteins confined within the cytosolic, nuclear and mitochondrial compartments. 
rPVL displays significantly stronger affinity for GlcNAc over Neu5Ac residues as verified by 
thermal shift assays and surface plasmon resonance experiments, being therefore an excellent 
alternative to WGA. Labelling of rPVL with biotin or HRP (horseradish peroxidase) allows its 
useful and efficient utilization by Western blot. The staining of whole cell lysates with labelled-
rPVL was dramatically decreased in response to OGT (O-GlcNAc transferase) knockdown and 
seen to increase after pharmacological blockade of OGA (O-GlcNAcase). Also, HRP-rPVL 
seemed to be more sensitive than the anti-O-GlcNAc antibody RL2. Thus, rPVL is a potent new 
tool to selectively detect O-GlcNAcylated proteins. 
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INTRODUCTION 
O-GlcNAcylation (O-linked β-D-N-acetylglucosaminylation) is a dynamic post-translational 
modification that consists in the addition of a GlcNAc residue onto serine or threonine residues 
of a large number of nucleocytoplasmic and mitochondrial proteins. O-GlcNAc cycling is 
managed by two enzymes: OGT (O-GlcNAc transferase, Haltiwanger et al. 1992) that grafts 
the GlcNAc residue onto target proteins and OGA (O-GlcNAcase, Dong and Hart, 1994) that 
removes it. Discovered 30 years ago (Torres and Hart 1984; Lefebvre and Issad, 2015), O-
GlcNAcylation has now been demonstrated to participate in many physiological processes 
including transcription, translation, proteasomal degradation, and signal transduction (Ma and 
Hart 2014; Hardivillé and Hart, 2014).  It also participates in the folding of proteins by 
stabilizing nascent polypeptide chains (Zhu et al. 2015). Dysregulation in protein O-
GlcNAcylation is involved in many chronic diseases including cancer, diabetes, cardiovascular 
complications and Alzeimer’s (Lefebvre et al., 2013; Banerjee et al., 2016). 
Identifying O-GlcNAcylated proteins and mapping sites of modification is still challenging 
since this O-GlcNAc is highly labile and can be in competition with phosphorylation 
(Vercoutter-Edouart et al., 2015). Early detection approach used indirect methods such as the 
in vitro addition of a modified-galactose like GalNAz (azido-GalNAc) by the mutant Y289L 
GalT1 (Ramakrishnan and Qasba, 2002). Recent proteomic approaches are based on mass 
spectrometry and generally require an enrichment step. Specific tools, such as lectins, 
antibodies, or metabolic labeling, are therefore useful for both detection and enrichment. At the 
present time the few available antibodies  do not display optimal high affinity, pan-specificity 
and sensitivity for O-GlcNAc (Snow et al. 1987; Holt et al. 1987; Turner et al., 1990; Teo et al. 
2010; Zachara et al., 2011). WGA from Triticum vulgaris (Allen et al. 1973) and GSL-II from 
Griffonia simplicifolia (Lyer et al. 1976), two lectins isolated from plants, also bind to terminal 
GlcNAc of N-glycans, and to O-GlcNAc, but their affinity for GlcNAc is low. 
Recently, two fungal lectins, PVL and AAL-2, were demonstrated to be specific for terminal 
non-reducing GlcNAc residues. PVL was purified from the fruiting bodies and mycelium of 
Psathyrella velutina mushroom (Kochibe and Matta 1989). The crystal structure revealed an 
integrin-like β-propeller fold harboring six GlcNAc-binding sites (Cioci et al. 2006). 
Recombinant PVL (rPVL) was produced in Escherichia coli and demonstrated to efficiently 
label truncated N-glycans with terminal GlcNAc present on glycoconjugates in lung, breast and 
colon carcinomas (Audfray et al. 2015). AAL-2, the closely related lectin 2 from mushroom 
Agrocybe aegerita displays very similar specificity and structure (Jiang et al. 2012; Ren et al. 
2015). Both lectins show medium range affinity for GlcNAc in solution with dissociation 
constants varying between 50 to 150 µM depending on the measurement method (Audfray et 
al. 2015; Jiang et al. 2012; Ren et al. 2015). 
As fungal GlcNAc-binding lectins appear as promising candidates for the labeling of O-
GlcNAcylated proteins, we envisaged characterizing the use of rPVL to this purpose. Since 
PVL, as most GlcNAc-specific proteins, displays cross-reactivity with Neu5Ac (Ueda et al. 
1999), we first documented the much stronger affinity of rPVL for GlcNAc than for sialylated 
oligosaccharides. We then demonstrated, successfully, the use of labeled-rPVL for selective 
detection of O-GlcNAcylated proteins.  
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EXPERIMENTAL PROCEDURES 
Materials 
rPVL was produced and purified as previously described (Audfray et al. 2015). Biotinylation 
was performed using biotin (Sigma) following manufacturer’s instructions. Labelling of rPVL 
by horseradish peroxydase was performed using EZ–LinkTM Plus Activated Peroxidase kit 
(Thermo Scientific) and instructions therein. 
Binding assays  
Thermal shift assays were performed using a Mini Opticon Real Time PCR machine (BioRad 
Laboratories) with 0.5 mg mL-1 of protein diluted in 100 mM NaCl, 20 mM Tris pH 7.5, 100 
μM CaCl2, with or without monosaccharide in a total reaction volume of 25 μL. SYPRO Orange 
(Molecular Probes, CA) was used as a fluorescent probe detected at 530 nm. The temperature 
was raised using 1°C min-1 steps from 25°C to 100°C and fluorescence readings were taken at 
each interval. A minimum of two independent measurements were performed for each 
condition. 
Surface plasmon resonance (SPR) experiments were performed on a Biacore X100 instrument 
(GE Healthcare) at 25°C. Biotinylated 3’-sialyllactose and biotinylated 6’-sialyllactose 
(Lectinity) were immobilized on CM5sensor chips (GE Healthcare) that were coated with 
streptavidin using the standard procedure. Each biotinylated sugar was diluted to 1 mg.mL-1 in 
HBS-T buffer (10 mM HEPES/NaOH, 150 mM NaCl, 0.05% Tween 20, pH 7.5)  before being 
injected in one of the flow cells of the chip. Low immobilization levels 94 and 64 response units 
(RU) were obtained for 3’-sialyllactose and 6’-sialyllactose respectively. A chip with low 
density surface of GlcNAc was obtained by immobilizing a mixture of 10% biotinylated 
GlcNAc-PAA and 90% Fuc-PAA (Lectinity), giving a final 270 RU.  A reference surface was 
always present in flow cell 1, thus allowing for the subtraction of bulk effects and non-specific 
interactions with streptavidin. The running buffer consisted of HBS-T buffer supplemented 
with 100 μM of CaCl2 at a flow rate of 30 μL min-1. rPVL was injected on flow cell surface at 
30 µL min-1 in series of 2-fold dilutions (association 360 s, dissociation 400 s). Regeneration 
of the chips was performed with 0.5 M GlcNAc solution. Binding was measured as resonance 
units over time after blank subtraction, and data were then evaluated by using the Biacore X100 
evaluation software, version 2.0. Dissociation constants were determined by plotting response 
at equilibrium (Req, 10 s before the end of injection) against analyte concentration. 
 
Staining of cell lysates O-GlcNAcylated proteins with biotin- and HRP-rPVL 
HepG2 (hepatocellular carcinoma-derived cell line) and HCT116 (colorectal carcinoma-
derived cell line) cells were maintained in a Dulbecco’s modified Eagle’s medium (DMEM, 
Lonza) and CCD841CoN cells (fetal normal colon cell line) were maintained in an Eagle’s 
Minimum Essential Medium (EMEM, Lonza). The three cell lines were supplemented with 
10% (v/v) fetal calf serum and 2 mM L-Glutamine at 37°C in a humidified atmosphere enriched 
with 5% (v/v) CO2. HepG2 cell culture dishes were preliminary coated with 0.1% (w/v) porcin 
gelatin (Sigma). For siOGT experiments, cells were reverse-transfected with Lipofectamine 
RNAiMax (Life Technologies) according to the manufacturer’s instructions using 5 nM small 
interfering RNA targeting OGT (Steenackers et al. 2016) or a control siRNA (MISSION siRNA 
universal negative control #1, Sigma). Thiamet-G (Sigma) was used at a final concentration of 
1 µM for 18 h. Cells were lysed in the following buffer: 10 mM Tris/HCl, 150 mM NaCl, 1 
mM EDTA, 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 
protease inhibitors, pH 7.4). 
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Equal amounts of protein (determined by the BCA method) were resolved on 10% SDS-PAGE 
under reducing conditions and proteins were electroblotted on nitrocellulose (GE Healthcare). 
Efficiency of the transfer and equal loading were verified using Ponceau red staining. 
Membranes were first saturated for 45 min with 4% (w/v) Grade V bovin serum albumin 
(Sigma) in Tris-buffered saline (TBS)-Tween buffer [15 mM Tris/HCl, 140 mM NaCl, and 
0.05% Tween20 (v/v), pH 8.0]. Membranes were incubated with biotin-rPVL (followed by an 
incubation with HRP-avidin at a dilution of 1:10,000) or HRP-rPVL at the indicated dilutions 
(starting dilutions: 0.6 mg.mL-1 and 1 mg.mL-1 for biotin-rPVL and HRP-rPVL respectively) 
in TBS for 1 hour at 4 °C, or overnight with the mouse monoclonal anti-O-GlcNAc (RL2, 
VWR) at a dilution of 1:3,000 in 5% (w/v) nonfat milk, followed by three washes with TBS-
Tween and then incubated with an anti-mouse horseradish peroxidase-labeled secondary 
antibody (GE Healthcare) at a dilution of 1:10,000 for 1 h. The mouse monoclonal antibody 
anti-GAPDH (Santa Cruz Biotechnologies) was used at a dilution of 1:5,000. Finally, three 
washes of 10 min each were performed with TBS-Tween and the detection was carried out by 
chemiluminescence imaging (Fusion Solo system, Vilber Lourmat).  
 
RESULTS  
 
Fine specificity of rPVL  
PVL is a GlcNAc-binding protein that was also shown to bind weakly to Neu5Ac (Ueda et al. 
1999). When assayed by ITC, affinity for Neu5Ac was below the millimolar (mM) range 
evading its precise quantification (Cioci et al. 2006). In order to evaluate the interaction between 
rPVL and both monosaccharides, thermal shift assays (TSA) and surface plasmon resonance 
(SPR) experiments were conducted (Fig. 1). 
The stability of rPVL was verified by TSA with a melting temperature (Tm) of 55 °C which was 
increased to 58 °C in presence of GlcNAc (Fig. 1A). A positive ΔTm value indicates that the 
ligand binds to the protein and stabilizes the protein from denaturation. These results are in 
agreement with previous experiments (Audfray et al. 2015) and with the structural observation 
of GlcNAc residues binding between the blades, therefore stabilizing the fold  (Cioci et al. 
2006). On the contrary, the presence of Neu5Ac residue does not bring any stabilization, with 
a steady Tm of 55 °C. No significant binding of rPVL to Neu5Ac could therefore be observed 
with this approach. 
In order to evaluate the affinity of rPVL to multivalent epitopes, SPR experiments were 
conducted using a chip prepared with low density of GlcNAc, to avoid crowding effect (Fig. 
1B). The dissociation constant was evaluated from steady state analysis at 67 nM. This affinity 
is 2000 times stronger than the one observed for monovalent GlcNAc (Kd of 134 µM by SPR 
and 126 µM by ITC) (Audfray et al. 2015). The donut shape of the PVL β-propeller with all 6 
binding sites on the same face is therefore very efficient for binding to multivalently presented 
GlcNAc. 
SPR was also performed with chips prepared with sialylated oligosaccharides (Fig S1 in Supp. 
information). The binding was weaker than for the GlcNAc chip, and even at high 
concentrations of PVL it was not possible to attain a binding plateau. Dissociation constants 
were evaluated from the steady state equilibrium with values of 1.88 µM and 0.76 µM for 
surfaces of 3’-sialyllactose and 6’-siallylactose, respectively. These results confirm that rPVL 
has a strong specificity for GlcNAc, with clear multivalency effect resulting in very high 
affinity for proteins or surfaces with multiple GlcNAc. Binding to sialylated oligosaccharides 
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is more than 10 times weaker but should be considered when analyzing surface glycoproteins. 
This cross-reactivity is nevertheless not of concern for nucleocytoplasmic glycoproteins. 
 
Staining of whole cell lysates with biotin or HRP-labelled-rPVL 
rPVL was biotinylated as indicated under the experimental procedures. Biotin-rPVL was tested 
at a dilution of 1:500 (corresponding to a final dilution of 1.2 µg.mL-1) by Western blot (  alone 
or in the presence of free GlcNAc) on two cell lines, HepG2 and HCT116 (Fig. 2A). To control 
the specificity of the lectin, cells were transfected with siRNA in order to silence OGT (versus 
siCtrl). HRP-avidin was also incubated without prior staining with biotin-rPVL (Fig. 2A). rPVL 
binds to numerous proteins but remaining bands appear after incubation of the lectin with 0.5 
M GlcNAc; also, proteins were still detected by HRP-avidin alone. The remaining bands likely 
correspond to naturally biotin-labelled proteins as previously described for fibroblasts in culture 
(Chandler 1986). Biotin is a post-translational modification found in different carboxylases 
including acetylCoA carboxylase or pyruvate carboxylase. In contrast, staining with the anti-
O-GlcNAc antibody RL2 was totally abolished when co-incubated with GlcNAc and nearly all 
bands disappeared for OGT knockdown cells (Fig. 2B).  
To avoid recognition of biotinylated proteins we therefore opted for a direct HRP labelling (Fig. 
3). As expected, we observed that the signal was greatly enhanced for HRP-rPVL compared to 
biotin-rPVL: even for the higher dilutions of rPVL, GlcNAc-bearing proteins were detected 
and OGT knockdown dramatically decreased the signal. When used at a dilution of 1:5,000 
(corresponding to 0.2 µg.mL-1) the profile of detection and the signal/background ratio were 
equivalent to those obtained by the RL2 blotting at a concentration of 0.66 µg.mL-1. Incubation 
of HRP-rPVL with 0.5 M GlcNAc showed that most of the signal was lost, strengthening the 
specificity of the lectin. HRP-rPVL blots were not significantly different when blocking by 
BSA was compared to blocking by milk; on the contrary RL2 blots were significantly stronger 
with BSA blocking, albeit not as sensitive as the detection by rPVL (Fig S2 in Supp. 
information). Lastly, the potent and selective OGA inhibitor Thiamet-G (Yuzwa et al. 2008) 
was tested on cultured-cells (Fig. 4). Blockade of OGA activity increased the staining with 
HRP-rPVL and with the anti-O-GlcNAc antibody RL2. Co-incubation of the lectin with 0.5 M 
GlcNAc strongly decreased its interaction with O-GlcNAcylated proteins. 
 
 
DISCUSSION 
Recombinant lectins are a tool of choice for glycomics research (Oliveira et al. 2013). They 
have constant quality and yield more reproducible results than lectins obtained from plants or 
other natural sources. Recombinant lectins are easily produced and purified at much lower cost 
than antibodies. One of their drawbacks is still their relatively low affinity for carbohydrates, 
but as demonstrated here, this is compensated by cluster effect when the epitope is presented in 
a multivalent manner. 
rPVL appears therefore as a good alternative to antibodies or to plant lectins for labeling O-
GlcNAc proteins. As for other GlcNAc-binding proteins like WGA (Monsigny et al. 1979), 
PVL presents some cross-reactivity with Neu5Ac due to the mimicry of the two 
monosaccharides (it is why succinylated-WGA is preferentially used for GlcNAc-specific 
staining). Nevertheless, when comparing glycan array data from the Consortium for Functional 
Glycomics obtained with rPVL (Audfray et al. 2015) and with WGA (see 
http://www.functionalglycomics.org), it is clear that rPVL recognizes almost exclusively 
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terminal non-reducing GlcNAc, while WGA binds to a variety of other epitopes, including 
terminal Neu5Ac and internal GlcNAc. In the present work, we confirm that rPVL affinity for 
Neu5Ac is at least one order of magnitude lower than for GlcNAc and does not represent a 
problem when working on cell lysates. 
While both biotin-rPVL and HRP-rPVL label efficiently O-GlcNAcylated proteins, the former 
does not allow the with discrimination intrinsically biotinylated proteins because of its use in 
conjunction with HRP-avidin. Moreover, HRP-PVL showed much higher sensitivity than the 
widely used anti-O-GlcNAc RL2 antibody (Snow et al. 1987; Holt et al. 1987). 
Together, these different approaches show that rPVL is a promising tool for studying the 
dynamics of O-GlcNAcylation processes. In the near future one can foresee rPVL conjugated 
with different molecules (HRP, Alexa Fluor, FITC, rhodamine, ferritin) to be conveniently 
accessible, allowing its use by ELISA, confocal microscopy, electronic microscopy, co- or 
immunoprecipitation, and immunohistology. 
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Legends for figures 
 
  
Figure 1. A. Thermal stability of rPVL as denaturation curve derivatives for the lectin alone 
(black lines) or in presence of GlcNAc (blue lines) or Neu5Ac (red lines) (RFU: Relative 
Fluorescence Units; two run per samples). B. SPR analysis of binding of rPVL to low-density 
GlcNAc chip:  Left: Sensorgrams measured at concentrations decreasing from 0.6 µM (top 
green line) in a 2-fold ratio to 4.7 nM (bottom green line). Red lines: control with no rPVL. 
Right:  steady state analysis resulting in a Kd of 67 nM. 
 
 
Figure 2. Whole cell lysates were prepared with HCT116 and HepG2 cells cultured with OGT 
siRNA or control siRNA. Proteins were resolved by SDS-PAGE and electroblotted onto 
nitrocellulose. A. Biotin-rPVL was incubated alone or in conjunction with free GlcNAc. 
Specificity of binding was also tested by incubation of HRP-avidin alone. B. Biotin-rPVL 
staining was compared to anti-O-GlcNAc immunoblots. 
Control of loading was checked with anti-GAPDH antibody. 
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Figure 3. Proteins were prepared as described in figure 2. A. HRP-rPVL was tested for various 
dilutions. A control of specificity was performed by incubation of the lectin with free GlcNAc 
(Right). B. HRP-rPVL staining was compared to anti-O-GlcNAc immunoblots. 
Control of loading was checked with anti-GAPDH antibody. 
 
 
 
Figure 4. CCD841CoN were cultured in presence or in absence of Thiamet-G, an inhibitor of 
the glycosylhydrolase OGA. A. HRP-rPVL was tested for two different dilutions (Left). A 
control of specificity was performed by incubation of the lectin (dilution: 1:500) with free 
GlcNAc (Right). B. HRP-rPVL staining was compared to anti-O-GlcNAc immunoblots. 
Control of loading was checked with anti-GAPDH antibody. 
